Zevra Therapeutics Inc (ZVRA)
NASDAQ
Quarter End | 12 2022 | 3 2023 | 6 2023 | 9 2023 | 12 2023 | 3 2024 | 6 2024 | 9 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
総資産 | 115.53M | 106.6M | 105.52M | 138.98M | 172.33M | 151.28M | 144.41M | 191.55M |
流動資産合計 | 93.02M | 104.28M | 103.43M | 137.01M | 86.94M | 62.89M | 60.89M | 99.44M |
現金および同等物 | 65.47M | 40.18M | 66.2M | 43.27M | 43.05M | 42.85M | 39.26M | 54.04M |
非流動資産合計 | 23.3M | 2.32M | 2.09M | 1.97M | 86.13M | 88.39M | 83.52M | 92.11M |
負債合計 | 29.72M | 35.19M | 37.02M | 71.51M | 110.46M | 102.47M | 111.93M | 121.78M |
流動負債合計 | 11.73M | 15.62M | 18.25M | 21.71M | 73.72M | 29.91M | 30.45M | 34.48M |
非流動負債合計 | 30.8M | 32.49M | 31.48M | 93.67M | 41.81M | 115.55M | 139.81M | 146.2M |
普通株 | 3k | 3k | 3k | 3k | 4k | 4k | 4k | 5k |
留保所得 | -308.57M | -320.34M | -325.42M | -339.47M | -399.78M | -416.4M | -436.33M | -469.55M |
年末 2023年12月31日 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
総資産 | 84.89M | 52.46M | 26.75M | 10.51M | 11.21M | 132.94M | 115.53M | 172.33M |
流動資産合計 | 74.36M | 47M | 23.72M | 6.63M | 8.38M | 115.06M | 93.02M | 86.94M |
現金および同等物 | 16.76M | 10.87M | 18.41M | 3.22M | 4.21M | 112.35M | 65.47M | 43.05M |
非流動資産合計 | -18.7M | -57.52M | -66.57M | -74.46M | -66.41M | 127.12M | 85.81M | 61.86M |
負債合計 | 103.58M | 109.97M | 93.31M | 84.96M | 77.62M | 5.82M | 29.72M | 110.46M |
流動負債合計 | 6.64M | 11.51M | 12M | 5.43M | 7.54M | 4.23M | 11.73M | 73.72M |
非流動負債合計 | 188.11M | 188.42M | 159.81M | 157.04M | 138.16M | 1.6M | 30.8M | 41.81M |
総資本 | -18.7M | -57.52M | -66.57M | -74.46M | -66.41M | 127.12M | 85.81M | 61.86M |
普通株 | 1,000 | 1,000 | 3k | 4k | 0 | 4k | 3k | 4k |
留保所得 | -121.34M | -164.73M | -221.19M | -245.71M | -258.47M | -267.03M | -308.57M | -399.78M |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約